Elsevier

Human Pathology

Volume 28, Issue 7, July 1997, Pages 779-785
Human Pathology

Original contribution
Loss of heterozygosity of chromosome 14q in low- and high-grade meningiomas

https://doi.org/10.1016/S0046-8177(97)90149-0Get rights and content

Abstract

Abnormalities of chromosome 22q have been well studied as a major molecular genetic event in meningiomas. Chromosome 14q loss has also been shown to be a common phenomenon. However, only a few studies have reported molecular genetic changes of this chromosome in meningioma. In this study, we examined 41 sporadic meningiomas of different histological subtypes and grades with 15 polymorphic microsatellite markers covering a wide region on chromosome 14q. Overall, 37% (15 of 41) of cases showed loss of heterozygosity for one or more allelic markers. Thirty percent (10 of 33) of benign tumors showed allelic losses, whereas 62.5% (5 of 8) of high-grade meningiomas showed loss of heterozygosity. There were altogether eight cases of partial deletions and seven cases of probable monosomy of 14q. Allelic losses of 14q were also commonly seen in recurrent tumors (3 of 3, 100%), parasagittal tumors (4 of 7, 57%), and tumors with transitional subtype (7 of 14, 50%). Among the tumors with allelic losses of 14q, all except one concurrently showed loss of heterozygosity for markers on 22q by our previous study. Of the eight cases with partial deletions, one showed losses on 14q11.1-31, two showed deletions on 14q24.3-31, three showed losses at 14q32.1-32.2, and the remaining two showed deletions at 14q24.3-32.2. We therefore defined two cluster regions of deletion on chromosome 14q: 14q24.3-31 and 14q32.1-32.2. Our studies suggested that more than one tumor suppressor gene(s) residing on distinct regions of chromosome 14q are important in the development and atypical or anaplastic changes in meningiomas.

References (47)

  • HK Ng et al.

    Combined molecular genetic studies of chromosome 22q and neurofibromatosis type 2 gene in central nervous system tumors

    Neurosurgery

    (1995)
  • JT Joseph et al.

    NF2 gene analysis distinguishes hemangiopericytoma from meningioma

    Am J Pathol

    (1995)
  • L Poulsgard et al.

    The cytogenetic and molecular genetic analysis of meningiomas

  • JP Dumanski et al.

    Deletion mapping of a locus on human chromosome 22 involved in the oncogenesis of meningiomas

  • P Merel et al.

    Predominant occurrence of somatic mutations of the NF2 gene in meningiomas and schwannomas

    Genes Chromosom Cancer

    (1995)
  • EL Matby et al.

    Cytogenetic studies in 50 meningiomas

    Cancer Genet Cytogenet

    (1988)
  • M Simon et al.

    Allelic losses on chromosomes 14, 10 and 1 in atypical and malignant meningiomas: A genetic model of meningioma progression

    Cancer Res

    (1995)
  • J Sambrook et al.
  • P Kleihues et al.

    World Health Organization: Histological Typing of Tumours of the Central Nervous System

    (1993)
  • J Jaakelainen et al.

    Atypical and anaplastic meningiomas: Radiology, surgery, radiotherapy and outcome

    Surg Neurol

    (1986)
  • A Mahmood et al.

    Atypical and malignant meningiomas: A clinicopathological review

    Neurosurgery

    (1933)
  • MA Cobb et al.

    Significance of proliferating cell nuclear antigen in predicting recurrence of intracranial meningioma

    J Neurosurg

    (1996)
  • J Weissenbach et al.

    A second-generation linkage map of the human genome

    Nature

    (1992)
  • Cited by (57)

    • A literature review of key molecular genetic aberrations in meningiomas: A potential role in the determination of radiosurgery outcomes

      2014, World Neurosurgery
      Citation Excerpt :

      Thus, these deletions are associated with meningioma progression, rather than initiation (1). Loss of 14q is associated with grade 2 and 3 meningiomas (1, 2, 11, 12, 19). Espinosa et al. (4) used array comparative genomic hybridization (a-CGH) to evaluate 25 meningiomas for 14q abnormalities and found such changes in 10 of 25 (40%) cases.

    • Primary Tumors of the Nervous System

      2013, Emery and Rimoin's Principles and Practice of Medical Genetics
    • Pathology and genetics of meningiomas

      2011, Seminars in Diagnostic Pathology
      Citation Excerpt :

      At the same time, more maps of these loci have generated further lists of candidate genes,40,43 the analyses of which are yet to be reported. Loss of 14q is associated with grade II and III meningiomas38,49-53 (Figure 11B). The 14q loss may also be a predictor of early recurrence in grade I meningiomas and poorer outcome in grade III meningiomas.53-55

    • Molecular genetics of meningiomas

      2005, Asian Journal of Surgery
    View all citing articles on Scopus
    View full text